$7.15
-0.28 (-3.77%)
Performance
1D
—
1W
—
1M
—
3M
-62.37%
6M
-62.37%
1Y
-62.37%
YTD
-62.37%
Open$7.50
Previous Close$7.43
Day High$7.50
Day Low$7.08
52W High$24.09
52W Low$5.50
Volume—
Avg Volume250.9K
Market Cap7.06B
P/E Ratio—
EPS$-0.67
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
72.7
Overbought
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.79M | 924.30M | 800.01M |
| Net Income | 130.26M | 123.87M | 128.43M |
| Profit Margin | 14.5% | 13.4% | 16.1% |
| EBITDA | 262.26M | 279.12M | 215.46M |
| Free Cash Flow | 117.43M | 106.34M | 120.15M |
| Rev Growth | +21.7% | -6.1% | -8.9% |
| Debt/Equity | 0.23 | 0.23 | 0.24 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| PICS | Pics Nv | $11.50 | -6.28% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.97 | +0.00% | — | 656.41M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.18B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.55 | -0.28% | 63.3 | 608.59M |
| CEPF | Cantor Equity Partners-Cl A | $10.20 | -0.29% | 356.7 | 584.55M |
| BCSS | Bain Capital Gss Inv- A | $10.11 | +0.10% | — | 593.34M |